Society for Endocrinology
Accessibility
Sitemap
Contact
Links
Large text
Small text
News
About
Grants
Careers
Events
Journals
Membership
Press Office
Public
Education
Corporate Members
Policy
You are here:
Home
>
Meetings and Events
> 196th SfE Meeting
Search
196th Meeting for the Society for Endocrinology
Programme: Wednesday 9 November 2006
Mon 7 Nov
|
Tues 8 Nov
| Wed 9 Nov |
Attended Posters
Download Programme (pdf) (138kb
)
09.00 – 10.30
Wolfson Theatre
Symposium:
Beta cell growth: implications of Type 1 and Type 2 diabetes
Chair: Docherty K (Aberdeen)
DS1
The onset of Type 2 diabetes - controlling the balance between beta-cell life and death
Rhodes C (Seattle, USA)
DS2
Islet mitogens - role in the maintenance of
b
-cell mass
Stoffel M (New York, USA)
DS3
Beta-cell death in Type 2 diabetes: a link to Type 1 diabetes
Donath M (Geneva, Switzerland)
DS4
Gain and loss of function strategies for directing human embryonic stem cell differentiation
Pedersen R (Cambridge)
10.30 – 11.00
Osler/Long Room
Coffee
11.00 – 12.00
Wolfson Theatre
Lecture:
Chair: Docherty K (Aberdeen)
DS5
Cell therapy to cure
Amiel S (London)
12.00 – 12.30
Wolfson Theatre
Meet the Expert:
Chair: Johnston C (Hemel Hempstead)
The role of the chemical pathologist in the modern management of diabetes
Kilpatrick E (Hull)
13.00 – 14.00
Osler/Long Room
Lunch
13.00 – 14.00
Library
Attended Posters
14.00 – 15.30
Wolfson Theatre
Meet the Experts: Managing the younger, lean, newly diagnosed patient
Chair: Johnston C (Hemel Hempstead)
The role of immunology
Leslie D (London)
The role of genetics
Hattersley A (Exeter)
15.30 – 16.00
Osler/Long Room
Tea
16.00– 17.00
Wolfson Theatre
Debate:
'This house believes that insulin is the treatment of choice for the poorly controlled, overweight patient with Type 2 diabetes'
Chair: Johnston C (Hemel Hempstead)
For: Davis M (Leicester)
Against: Scott A (Sheffield)